HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

In vitro and in vivo identification of a novel cytotoxic T lymphocyte epitope from Rv3425 of Mycobacterium tuberculosis.

Abstract
The identification of novel cytotoxic T lymphocyte (CTL) epitopes is important to analysis of the involvement of CD8(+) T cells in Mycobacterium tuberculosis infection as well as to the development of peptide vaccines. In this study, a novel CTL epitope from region of difference 11 encoded antigen Rv3425 was identified. Epitopes were predicted by the reversal immunology approach. Rv3425-p118 (LIASNVAGV) was identified as having relatively strong binding affinity and stability towards the HLA-A*0201 molecule. Peripheral blood mononuclear cells pulsed by this peptide were able to release interferon-γ in healthy donors (HLA-A*02(+) purified protein derivative(+)). In cytotoxicity assays in vitro and in vivo, Rv3425-p118 induced CTLs to specifically lyse the target cells. Therefore, this epitope could provide a subunit component for designing vaccines against Mycobacterium tuberculosis.
AuthorsFei Chen, Ming-xia Zhai, Yu-huang Zhu, Yuan-ming Qi, Wen-jie Zhai, Yan-feng Gao
JournalMicrobiology and immunology (Microbiol Immunol) Vol. 56 Issue 8 Pg. 548-53 (Aug 2012) ISSN: 1348-0421 [Electronic] Australia
PMID22537173 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2012 The Societies and Blackwell Publishing Asia Pty Ltd.
Chemical References
  • Bacterial Proteins
  • Epitopes, T-Lymphocyte
  • HLA-A*02:01 antigen
  • HLA-A2 Antigen
  • Interferon-gamma
Topics
  • Animals
  • Bacterial Proteins (immunology)
  • Computational Biology
  • Cytotoxicity Tests, Immunologic
  • Epitope Mapping
  • Epitopes, T-Lymphocyte (immunology)
  • HLA-A2 Antigen (metabolism)
  • Humans
  • Interferon-gamma (metabolism)
  • Leukocytes, Mononuclear (immunology)
  • Mice
  • Mice, Transgenic
  • Mycobacterium tuberculosis (immunology)
  • Protein Binding
  • T-Lymphocytes, Cytotoxic (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: